Global Flow Cytometry Market, By Technology (Cell-based Flow Cytometry, Bead-based Flow Cytometry), By Product (Instruments (Cell Analyzers, Cell Sorters), Reagents & Consumables, Software Accessories, Services), By End User (Commercial Organization, Hospitals, Academic Institutes, Clinical Testing Labs) and opportunities and forecast 2020-2027
Flow Cytometry Market Overview
Flow cytometry has emerged as a key tool for safety and exploratory purposes during the drug discovery and development processes. This tool is used right from pre-clinical trials to target identification and screening. Flow cytometry about analyze a large number of particles in a very short and provide and supply statistically strong information regarding cell populations. These skills, coupled with its multi-parametric approach, facilitate the adoption of flow cytometry in drug discovery and development processes within the pharmaceutical and biopharmaceutical industries.
Moreover, biomarker research has become regulatory integral a part of drug discovery and development. It provides valuable proof to guide clinical decisions, assesses the pharmacodynamics of drugs, and supports drug filings with regulative bodies. This also increases the value and acceleration process of a drug. Flow cytometry is wide used in biomarker analysis to monitor the development and differentiation of cell populations, evaluate target engagement and biomarker expression in cells, and assess cell functions and signalling events.
These growth opportunities are often attributed to the increasing analysis initiatives across key countries, low regulatory barriers, continuous improvements in healthcare infrastructures, growing patient population, rising attention expenditure, and strengthening distribution networks of market leaders in these regions. Moreover, regulative policies within the Asia Pacific area unit additional adaptational and business-friendly because of less rigorous rules and information necessities. This, in conjunction with increasing competition in mature markets, has more propelled key players within the flow cytometry market to target rising countries. for example, China features a sturdy attention infrastructure, a fast economy, rising domestic demand, and public-private initiatives that support analysis. Similarly, Bharat conjointly faces associate increasing prevalence of target diseases and features a fast-growing life science analysis industry.
Most finish users, like clinical laboratories, giant analysis facilities, and pharmaceutical corporations, need a big variety of flow cytometry instruments to hold out multiple analysis studies at the same time. This ends up in a big increase within the cost of capital related to the acquisition and maintenance of those devices. tutorial and analysis laboratories realize it tough to afford such instruments because of restricted budgets.
The covid-19 Impact on Flow Cytometry Market:
|Market size available for years
|Base year considered
||Value (USD Million)
||Technology, Product, End User and Region
||North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
||Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Sysmex Corporation, Stratedigm, Inc., Apogee Flow Systems Ltd.
Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount. Flow Cytometry Market Segment Overview
By Technology, the cell-based flow cytometry segment accounted for the largest share of the flow cytometry market in 2020.the world flow cytometry market is categorized into cell-based and bead-based flow cytometry. the cell-based flow cytometry segment accounted for the largest share of the flow cytometry market. Cell-based flow cytometry tests compound activity against molecular targets within the context of living cells, due to that they are progressively getting used in drug discovery processes. the supply of automatic technologies, like high-throughput flow cytometry for cell-based screening more drives the expansion of the cell-based flow cytometry market
By Product and service, By product and service, the reagents and consumables phase accounted for the largest share of the flow cytometry market in 2020.the market is categorized into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables phase dominates the flow cytometry market. Factors like the event and development of high-quality application-specific reagents and assays and therefore the continuous demand of flow cytometry reagents by end-users are expected to drive the expansion of the reagents and consumables market within the coming years.
By End User, The commercial organization segment dominated the marketplace for flow cytometry in 2020 . This dominance is attributable to increasing R&D activities by industrial organizations like pharmaceutical and biotechnology firms. additionally, increasing food industries in developing countries commercial China and India also are anticipated to support segment growth.
Market Analysis, Insights and Forecast – By Technology
· Cell-based Flow Cytometry
· Bead-based Flow Cytometry
Market Analysis, Insights and Forecast – By Product
- Cell Analyzers
- Cell Sorters
- Reagents & Consumables
Market Analysis, Insights and Forecast – By End User
· Commercial Organization
· Academic Institutes
· Clinical Testing LabsFlow Cytometry Market Regional Overview
Region-wise, in terms of regions, North America dominated the market for flow cytometry and held the largest revenue share in 2020. The region is anticipated to dominate the market throughout the study period. This dominance can be attributed to high healthcare expenditure, well-established healthcare infrastructure, and high adoption of technologically advanced flow cytometry solutions within the U.S. furthermore, the established pharmaceutical industry and extensive research activities by analysis universities and pharmaceutical corporations have created an enormous demand for flow cytometry solutions for research needs. additionally, the high prevalence of chronic and infectious diseases, including the happening of COVID-19, has led to a rise within the demand for flow cytometry solutions for diagnosis and analysis functions.
Flow Cytometry Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA) Flow Cytometry Market Competitor overview
Some key developments and strategies adopted by manufacturers in the flow Cytometry are highlighted below.
· In 2021, Thermo Fisher Scientific, Inc. (US) launched attune CytPix Flow Cytometer, a benchtop instrument that helps researchers working in QA/QC or cell therapy applications to collect extra info about cells and therefore the sample quality whereas running flow cytometry experiments without sacrificing speed or simplicity. Flow Cytometry Market, Key Players
· Danaher Corporation
· Dickinson and Company
· Luminex Corporation
· Agilent Technologies, Inc.
· Bio-Rad Laboratories, Inc.
· Miltenyi Biotec
· Sysmex Corporation
· Stratedigm, Inc.
· Apogee Flow Systems Ltd.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Flow Cytometry market during the forecast period?
A. Flow Cytometry market is expected to record a CAGR of ~9.1% during the forecast period.
Q2. Which segment is projected to hold the largest share in the Flow Cytometry Market?
A. Cell-based flow cytometry segment is projected to hold the largest share in the Flow Cytometry Market.
Q3. What are the driving factors for the Flow Cytometry market?
A. Flow cytometry about analyze a large number of particles in a very short and provide and supply statistically strong information regarding cell populations. These skills, coupled with its multi-parametric approach, facilitate the adoption of flow cytometry in drug discovery and development processes within the pharmaceutical and biopharmaceutical industries is key factors that boost the growth of the Flow Cytometry market progressively.
Q4. Which Segments are covered in the Flow Cytometry market report?
A. Technology, Product ,End User and Region, these segments are covered in the Flow Cytometry market report
Q5. Which are the prominent players offering Flow Cytometry?
A. Danaher Corporation , Becton , Dickinson and Company ,Luminex Corporation , Agilent Technologies, Inc. , Bio-Rad Laboratories, Inc. , Miltenyi Biotec , Sysmex Corporation , Stratedigm, Inc., Apogee Flow Systems Ltd